| |
| |
|
| Insider
Information: |
Watson David O. |
| Relationship: |
General Counsel |
| City: |
Crestwood |
| State: |
KY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
107,152 |
|
|
Indirect Shares
|
90,705 |
|
|
| Direct
Value |
$4,703,973 |
|
|
|
Indirect Value
|
$3,981,950 |
|
|
| Total
Shares |
197,857 |
|
|
| Total
Value |
$8,685,922 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
General Counsel |
2024-03-06 |
107,152 |
2024-03-06 |
90,705 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2024-03-06 |
4 |
OE |
$13.85 |
$52,104 |
D/D |
3,762 |
107,152 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2024-02-12 |
4 |
S |
$67.77 |
$52,926 |
D/D |
(781) |
103,390 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2024-01-29 |
4 |
S |
$64.14 |
$58,109 |
D/D |
(906) |
104,171 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2024-01-22 |
4 |
S |
$65.00 |
$271,943 |
D/D |
(4,184) |
105,077 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2024-01-16 |
4 |
S |
$66.81 |
$283,268 |
D/D |
(4,240) |
109,261 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
23,748 |
113,501 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-12-19 |
4 |
OE |
$13.85 |
$109,484 |
D/D |
7,905 |
93,658 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-12-19 |
4 |
S |
$57.00 |
$223,472 |
D/D |
(3,905) |
89,753 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-07-03 |
4 |
AS |
$89.98 |
$765,730 |
D/D |
(8,510) |
85,753 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• – – |
2023-06-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,750 |
80,705 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• – – |
2023-06-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,750 |
94,263 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-04-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
67,955 |
107,013 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-04-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
67,955 |
67,955 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• – – |
2023-02-21 |
4 |
D |
$58.50 |
$48,263 |
D/D |
(825) |
174,968 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• – – |
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
9,886 |
175,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-02-10 |
4 |
D |
$51.21 |
$27,244 |
D/D |
(532) |
165,907 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-01-27 |
4 |
D |
$52.77 |
$29,076 |
D/D |
(551) |
166,439 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-01-20 |
4 |
D |
$52.05 |
$105,870 |
D/D |
(2,034) |
166,990 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
53,455 |
169,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2022-06-22 |
4 |
S |
$44.51 |
$445,140 |
D/D |
(10,000) |
115,569 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2022-04-25 |
4 |
AS |
$50.00 |
$250,000 |
D/D |
(5,000) |
125,569 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2022-04-21 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,875) |
130,569 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2022-02-10 |
4 |
D |
$47.12 |
$23,136 |
D/D |
(491) |
132,444 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2022-01-28 |
4 |
D |
$38.59 |
$25,084 |
D/D |
(650) |
132,935 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
General Counsel |
• • – |
2022-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
26,051 |
133,585 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
